Benzinga | Jan 19, 2021 10:09AM EST

Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $251

Morgan Stanley maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and raises the price target from $249 to $251.